Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures and markets oral and sterile antibiotics, antibacterials, anti-ulcerants and other generic basic drugs.
Aurobindo Pharma Ltd, is a listed public company incorporated on 26 December, 1986. It is classified as a public limited company and is located in , Telangana. It's authorized share capital is INR 666.40 cr and the total paid-up capital is INR 58.08 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Girish Paman Vanvari | 07376482 | 5 years |
| Director | Venkata Ramprasad Reddy Penaka
Shareholder
|
01284132 | 33 years |
| Whole-time Director | Madan Mohan Reddy Mettu
Shareholder
|
01284266 | 13 years |
| Director | Sarath Chandra Reddy Penaka | 01628013 | 18 years |
| Managing Director | Nityananda Reddy Kambam
Shareholder
|
01284195 | 33 years |
| Director | Santanu Mukherjee | 07716452 | 3 years |
| Director | Satakarni Makkapati | 09377266 | 2 years |
| Director | Mangalam Ramasubramanian Kumar | 03628755 | 2 years |
| Director | Deepali Pant Joshi | 07139051 | 2 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 2,000.0 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| APL Pharma Thai Limited, | Thailand | - | - |
| All Pharma (Shanghai) Trading Corp Ltd, | China | - | - |
| Aurobindo Pharma Industria Farmaceutica Ltda | Brazil | - | - |
| Aurobindo Pharma Produtos Farmaceuticos Ltda | Brazil | - | - |
| Aurobindo Pharma Japan KK, | Japan | - | - |
| Auro Pharma Inc | Canada | - | - |
| Aurobindo Pharma (Pty) Ltd | South Africa | - | - |
| Aurovida Farmaceutica Sa De Cv | Mexico | - | - |
| Aurobindo Pharma Colombia Sas | Colombia | - | - |
| Aurogen South Africa (Pty) Ltd | South Africa | - | - |
| Aurobindo Pharma Saudi Arabia Ltd Co | Saudi Arabia | - | - |
| Aurovitas Pharma (Taizhou) Ltd | China | - | - |
| Aurobindo Pharma USA Inc | United States | - | - |
| Aurolife Pharma LLC | United States | - | - |
| Aurovitas Spol s.r.o . | Czech Republic | - | - |
| Auro Health LLC | United States | - | - |
| Auro AR LLC | United States | - | - |
| Auro Vaccines LLC | United States | - | - |
| AuroLogistics LLC | United States | - | - |
| Acrotech Biopharma Inc | United States | - | - |
| Helix Healthcare B.V. | Netherlands | - | - |
| Agile Pharma B.V | Netherlands | - | - |
| Ace Laboratories Limited | United Kingdom | - | - |
| Aurex B.V | Netherlands | - | - |
| Milpharm Limited | United Kingdom | - | - |
| Aurobindo Pharma (Malta) Ltd | Malta | - | - |
| APL Swift Services (Malta) Ltd | Malta | - | - |
| Aurovitas Nederland B.V | Netherlands | - | - |
| Aurobindo Pharma (Romania) s.r.l | Romania | - | - |
| Pharmacin B.V. (formerly known as Aurex B.V.) | Netherlands | - | - |
| Aurobindo Pharma (Italia) S.r.l | Italy | - | - |
| Arrow Generiques SAS | France | - | - |
| 1980 Puren Pharma GmbH | Germany | - | - |
| Puren Pharma GmbH & Co. KG | Germany | - | - |
| Aurovitas Spain SA | Spain | - | - |
| Aurovitas Pharma Polska | Poland | - | - |
| Generis Farmacêutica SA | Portugal | - | - |
| Generis Phar, Unipessoal Ltda | Portugal | - | - |
| APL HEALTHCARE LIMITED | Telangana | 2006 | ₹ 216.0 Cr |
| Aurobindo Pharma Foundation (Sec 8 Company) | India | - | - |
| AURO PEPTIDES LIMITED | Telangana | 2012 | ₹ 319.1 Cr |
| APITORIA PHARMA PRIVATE LIMITED | Telangana | 2017 | ₹ 99.0 Cr |
| Aurobindo Pharma FZ LLC | United Arab Emirates | - | - |
| PT Aurogen Pharma Indonesia | Indonesia | - | - |
| Purple Bellflower, South Africa | South Africa | - | - |
| Auro Science LLC | United States | - | - |
| Auro Pharma LLC | Russian Federation | - | - |
| Apotex Europe B.V. | Netherlands | - | - |
| Sameko Farma B.V. | Netherlands | - | - |
| Leida pharm B.V | Netherlands | - | - |
| Marel B.V. | Netherlands | - | - |
| Pharma Dossier B.V. | Netherlands | - | - |
| Auro Packaging LLC | United States | - | - |
| Aurobindo NV/SA (w.e.f. 17 December 2019) | Belgium | - | - |
| AUROACTIVE PHARMA PRIVATE LIMITED | Telangana | 2020 | ₹ 247.0 Cr |
| CURATEQ BIOLOGICS PRIVATE LIMITED | Telangana | 2020 | ₹ 102.1 Cr |
| EUGIA STERILES PRIVATE LIMITED | Telangana | 2020 | ₹ 44.2 Cr |
| AUROZEST PRIVATE LIMITED | Telangana | 2020 | ₹ 10.0 L |
| AUROBINDO ANTIBIOTICS PRIVATE LIMITED | Andhra Pradesh | 2020 | ₹ 1.0 Cr |
| LYFIUS PHARMA PRIVATE LIMITED | Andhra Pradesh | 2020 | ₹ 10.0 L |
| QULE PHARMA PRIVATE LIMITED | Andhra Pradesh | 2020 | ₹ 10.0 L |
| EUGIA SEZ PRIVATE LIMITED | Telangana | 2021 | ₹ 4.0 Cr |
| EUGIA PHARMA SPECIALITIES LIMITED | Telangana | 2013 | ₹ 621.0 Cr |
| Aurobindo Pharma B.V. (formerly known as Actavis B.V.) | Netherlands | - | - |
| CuraTeQ Biologics s.r.o | Czech Republic | - | - |
| Eugia Pharma B.V | Netherlands | - | - |
| Eugia Pharma (Malta) Limited | Malta | - | - |
| Eugia (UK) Limited | United Kingdom | - | - |
| Aurosalud SA De CV | Mexico | - | - |
| Auro PR Inc | Puerto Rico | - | - |
| Eugia Pharma INC | Canada | - | - |
| Eugia Pharma (Australia) PTY Limited | Australia | - | - |
| Eugia Pharma Industria Farmaceutica Limitada | Brazil | - | - |
| Eugia US LLC. | United States | - | - |
| Aurobindo Pharma Ukraine LLC | Ukraine | - | - |
| Eugia Pharma Colombia S.A.S | Colombia | - | - |
| THERANYM BIOLOGICS PRIVATE LIMITED | Telangana | 2022 | ₹ 10.0 L |
| Vespyr Brands, Inc (formerly known as Nurya Brands Inc) | United States | - | - |
| Eugia US Manufacturing LLC | United States | - | - |
| AURO PHARMA LIMITED | India | - | - |
| Eugia Inc | United States | - | - |
| AURO VACCINES PRIVATE LIMITED | Telangana | 2021 | ₹ 10.0 L |
| GLS PHARMA LIMITED | India | - | - |
| AURO TRADING PRIVATE LIMITED | India | - | - |
Read more
The incorporation date of AUROBINDO PHARMA LTD is 26 December, 1986
The authorized share capital of AUROBINDO PHARMA LTD is INR ₹ 666.4 Cr.
The paid-up capital of AUROBINDO PHARMA LTD is INR ₹ 58.1 Cr.
The registered address of AUROBINDO PHARMA LTD is PLOT NO.2, MAITHRIVIHAR, BEHIND MAITHRI VANAM, AMEERPET, HYDERABAD, Telangana, India, 500038 - 500038
The CIN number of AUROBINDO PHARMA LTD is L24239TG1986PLC015190.